Category Archives: Events
Latest From Events
Angie Drakulich, one of our BIO Official Bloggers, attended this morning Partnerships for Global Health Forum. This event, part of the 2011 BIO International Convention, is an annual event sponsored by BIO and BioVentures for Global Health. In her blog Angie says: What many Americans may not understand when they think of global health is how much it affects the country’s relationships and connectedness to other nations. One audience member suggested renaming the term “global Read More >
Thanks to Yali (BIO Official Blogger) for reminding us that Mark Ahn, Michael Alvarez, and Anne York, the editors of Building the Case for Biotechnology: Management Case Studies in Science, Laws, Regulations, Politics, and Business will be signing books today at the 2011 BIO International Convention in Washington DC from 3:00-4:30 pm in the BIO bookstore.
BIOtechNOW’s Tracy Cooley talks to Dr. Schubert of the Bioscience Association of West Virginia about biotech in West Virginia – major areas of growth, the outlook for growth of the industry within the state, and plans for the upcoming BIO International Convention. Download the podcast
Angie Drakulich from PharmaTech Talk writes: Next week is the annual Biotechnology Industry Organization (BIO) Convention in Washington, DC. Many of our editorial team members will be there and we hope to see you. With a regulatory pathway for biosimilars underway in the United States, renewed conversations about regenerative medicine, and a booming biotech sector, the convention should be quite dynamic. Angie is part of our BIO Official Blog Program. Keep an eye on her Read More >
Andrew Williams wrote a second part to his original blog entry on 2011 BIO International Convention preview… This time his focus is on Biosimilars: For BIO attendees interested in learning more about the relatively new pathway for FDA approval of biosimilars, also known as follow-on biologics, there are several sessions devoted to the intricacies of the new law, or how the new legislation is impacting the BIO community. The biosimilar framework was introduced last year Read More >